Northern Trust Corp Compugen LTD Transaction History

Northern Trust Corp

$690 Billion
Q4 2024

A detailed history of Northern Trust Corp transactions in Compugen LTD stock. As of the latest transaction made, Northern Trust Corp holds 941,825 shares of CGEN stock, worth $2.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

941,825

Previous 90,828 936.93%

Holding current value

$2.09 Million

Previous $164,000 778.05%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.41 - $1.93 $1.2 Million - $1.64 Million	850,997 Added 936.93%	941,825 $1.44 Million
Q3 2024 Nov 13, 2024	SELL	$1.56 - $2.1 $6,177 - $8,316	-3,960 Reduced 4.18%	90,828 $164,000
Q2 2024 Aug 14, 2024	SELL	$1.68 - $2.52 $10,123 - $15,185	-6,026 Reduced 5.98%	94,788 $159,000
Q1 2024 May 14, 2024	SELL	$1.75 - $2.95 $22,781 - $38,403	-13,018 Reduced 11.44%	100,814 $260,000
Q4 2023 Feb 13, 2024	BUY	$0.53 - $2.0 $60,330 - $227,664	113,832 New	113,832 $225,000
Q2 2023 Aug 11, 2023	BUY	$0.57 - $1.38 $11,269 - $27,283	19,771 New	19,771 $22,000
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $22,005 - $46,673	-14,016 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.76 - $4.64 $4,454 - $7,488	-1,614 Reduced 10.33%	14,016 $45,000
Q4 2021 Feb 08, 2022	SELL	$4.09 - $7.16 $3,852 - $6,744	-942 Reduced 5.68%	15,630 $67,000
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $487,977 - $674,754	-84,134 Reduced 83.54%	16,572 $99,000
Q2 2021 Aug 13, 2021	SELL	$6.87 - $9.16 $5,619 - $7,492	-818 Reduced 0.81%	100,706 $833,000
Q1 2021 May 12, 2021	SELL	$7.67 - $13.77 $3,443 - $6,182	-449 Reduced 0.44%	101,524 $872,000
Q3 2020 Nov 16, 2020	BUY	$14.16 - $19.45 $22,429 - $30,808	1,584 Added 1.58%	101,973 $1.66 Million
Q2 2020 Aug 14, 2020	BUY	$6.97 - $17.12 $699,711 - $1.72 Million	100,389 New	100,389 $1.51 Million

Others Institutions Holding CGEN

# of Institutions

Shares Held

13.4M

Call Options Held

44.9K

Put Options Held

8.1K

View Full List

About COMPUGEN LTD

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $192M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

More about CGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Compugen LTD Transaction History